Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical and Virologic Significance of Zidovudine Resistance
NCT00001025Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in human immunodeficiency virus infection (HIV) comparing Continue AZT, Switch to ddI and AZT + ddI (3 arms). Status: completed.
02
Drugs
didanosinezidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001025.